Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.63%)
As of: Sep 9, 2026 · 2:27 PM EDT

Viatris (VTRS) Operating Expenses (2019 - 2026)

Viatris (VTRS) posted Operating Expenses of $1.5 billion for Q2 2026, up 17.24% on a QoQ basis from $1.2 billion in Q1 2026, and up 31.85% year-over-year from $1.1 billion in Q2 2025.

Analysis

Viatris (VTRS) Operating Expenses (2019 - 2026) Analysis & Trends

Viatris has reported Operating Expenses for 8 years, with the latest figure at $1.5 billion in Q2 2026.

  • On a quarterly basis, Operating Expenses rose 31.85% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $5.2 billion, a 32.83% decrease from a year earlier, with the FY2025 full-year figure at $7.7 billion, up 36.75% from the prior year.
  • Operating Expenses was $1.5 billion for Q2 2026 at Viatris, up from $1.2 billion in the prior quarter.
  • The five-year high for Operating Expenses was $4.0 billion in Q1 2025, with the low at $1.1 billion in Q1 2022.
  • Average Operating Expenses over 5 years is $1.5 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Operating Expenses soared 211.01% in 2025, then sank 69.41% in 2026.
  • Over 5 years, Operating Expenses stood at $1.5 billion in 2022, then surged by 39.01% to $2.1 billion in 2023, then slumped by 31.99% to $1.4 billion in 2024, then declined by 3.89% to $1.3 billion in 2025, then advanced by 8.18% to $1.5 billion in 2026.
  • The last three Operating Expenses figures came in at $1.5 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn 1.29 Bn
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn 1.45 Bn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 356.56 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn 195.34 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn 2.11 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -65.41 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 225.58 Mn
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn 53.74 Mn
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn 16.14 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.45 Bn
Mar 31, 2026 1.24 Bn
Dec 31, 2025 1.34 Bn
Sep 30, 2025 1.19 Bn
Jun 30, 2025 1.10 Bn
Mar 31, 2025 4.04 Bn
Dec 31, 2024 1.39 Bn
Sep 30, 2024 1.23 Bn
Jun 30, 2024 1.69 Bn
Mar 31, 2024 1.30 Bn
Dec 31, 2023 2.05 Bn
Sep 30, 2023 1.24 Bn
Jun 30, 2023 1.24 Bn
Mar 31, 2023 1.14 Bn
Dec 31, 2022 1.48 Bn
Sep 30, 2022 1.19 Bn
Jun 30, 2022 1.15 Bn
Mar 31, 2022 1.06 Bn
Dec 31, 2021 1.62 Bn
Sep 30, 2021 1.22 Bn